Canadian Drug Expert Committee (CDEC)

( Last Updated : October 11, 2017)

The Canadian Drug Expert Committee (CDEC) is an appointed, pan-Canadian advisory body to CADTH composed of individuals with expertise in drug therapy, drug evaluation and drug utilization, and public members (for a lay perspective).

As part of the CADTH Common Drug Review (CDR) process, CDEC makes recommendations to each of the participating federal, provincial, and territorial publicly funded drug plans regarding the listings on their formularies. It also makes recommendations related to the identification, evaluation, and promotion of optimal drug prescribing and use in Canada.

CDEC's approach is evidence based, and the advice reflects medical and scientific knowledge, current clinical practice, economics, ethical considerations, and patient and public impact.

CDEC is appointed by, and reports to, CADTH's President and CEO. Members must abide by the Conflict of Interest Guidelines for CADTH Expert Committee and Panel Members and the CADTH Code of Conduct. An honorarium is paid to CDEC members for their preparation and meeting time.

CDEC Terms of Reference

CDEC Meeting Schedule


Dr. Jim Silvius, BA (Oxon), MD, FRCPC

Dr. Jim SilviusDr. Silvius is an Associate Professor in the Cumming School of Medicine, Division of Geriatric Medicine, at the University of Calgary. At Alberta Health Services (AHS), he is the Provincial Medical Director of Seniors Health and the Senior Medical Director, Seniors Health Strategic Clinical Network. He was the previous Medical Director of AHS Pharmacy Services, a member of the Alberta Health and Wellness Expert Committee on Drug Evaluation and Therapeutics between 1999 and 2003, and chair of that committee from 2004 to 2015. He is also a former member of CADTH’s Canadian Optimal Medication Prescribing and Utilization Service (COMPUS) Expert Review Committee. Dr. Silvius maintains a clinical practice in geriatrics at Rockyview General Hospital. His other interests include dementia care, care delivery, and deprescribing at the Canadian Deprescribing Network (CaDeN) where he is a Co-Director.

Conflict of Interest Disclosure


Dr. Ahmed Bayoumi, MSc, MD

Dr. Ahmed BayoumiDr. Bayoumi is a scientist at the Centre for Research on Inner City Health at the Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael's Hospital. He is also a general internist and HIV physician at St. Michael's Hospital, and past Director of Clinical Epidemiology and Health Care Research at the University of Toronto's Institute of Health Policy, Management and Evaluation. His research interests include equity and resource allocation, economic evaluation, quality of life assessment for HIV-related health interventions, and access to health services delivery for marginalized populations, including people living with HIV and people who use drugs. Ahmed is an adjunct scientist at the Institute for Clinical Evaluative Sciences. He is President of the Society for Medical Decision Making for 2014 to 2015.

Conflict of Interest Disclosure

Dr. Bruce C. Carleton, PharmD

Dr. Bruce C. CarletonDr. Carleton earned a bachelor's degree in pharmaceutical sciences from Washington State University and a Doctor of Pharmacy from the University of Utah. He joined the University of British Columbia in 1991, and is currently Professor of Pediatrics and Pharmaceutical Sciences and Co-Chair, Division of Translational Therapeutics, in the Faculty of Medicine. Bruce also serves as Director, Pharmaceutical Outcomes Programme, BC Children's Hospital, and is Senior Clinician Scientist at the Child & Family Research Institute in Vancouver, British Columbia. His research focuses on the impact of drug therapy on human health and quality of life. He is particularly interested in developing better ways to evaluate the effectiveness of drugs, medication-use models designed to improve patient health, and practical surveillance systems to improve the safe use of medication. Bruce has particular clinical interests in asthma and the clinical use of drugs in children; and in the epidemiology, pharmacogenomics, and clinical management of adverse drug events.

Conflict of Interest Disclosure

Dr. Alun Edwards

Dr. Alun EdwardsAlun Edwards is Professor of Medicine at the Cumming School of Medicine, University of Calgary, and a clinical endocrinologist. He has a longstanding interest in the pragmatic translation of evidence into practice, and in considering resource distribution in health system development and outcomes measurement.

His most recent work in this area was as the inaugural Senior Medical Director for the Alberta Health Services Diabetes, Obesity and Nutrition Strategic Clinical Network. He also chaired the Quality Improvement Committee of the Canadian Society of Endocrinology and Metabolism, which developed recommendations for the specialty.

Conflict of Interest Disclosure

Mr. Bob Gagne

Mr. Bob GagneBob Gagne holds an MBA from York University and a BSc from Western University. He has held a number of senior leadership roles over the past 30 years including four years in planning and strategy development with a global financial institution, eight years as director of information technology in a teaching hospital in Toronto, and three years as director of strategic technology for a top Canadian Internet portal. Most recently he was the chief information officer at York University for eighteen years before retiring in 2017. Bob has served on multiple industry and community boards of directors including the boards of Onet, GTAnet networking, the Canadian University Council of CIOs, and the Canadian Association for Tay-Sachs and Allied Diseases. He is currently a member of the board of CANARIE. His experience with, and appreciation for, Canada’s health care system was strongly shaped by the life and care of his daughter Elizabeth who was born with Tay-Sachs disease, a rare, neurodegenerative genetic disorder.

Conflict of Interest Disclosure

Dr. Ran Goldman

Dr. Ran Goldman Dr. Ran Goldman is a professor of pediatrics, a clinician-investigator and pediatrician, with a fellowship in pediatric emergency medicine and clinical pharmacology and toxicology. He did his specialized training in Toronto, and served as a Staff Physician at the Hospital for Sick Children (SickKids). He was then recruited to BC Children’s Hospital as the Chief of Emergency Medicine. Dr. Goldman also served as the Assistant Dean of Continuing Education at the University of British Columbia. He is currently the University’s Co-Chair of the Division of Pediatric Translational Therapeutics in the Faculty of Medicine, and a member of the BC Children’s Hospital Research Institute.

Dr. Goldman completed a Master of Health Research Methodology and trains numerous students in conducting effective research. His research program focuses on pain in the acute care setting and his lab findings resulted in an improved pain management approach for children worldwide. With more than 150 peer-reviewed publications, Dr. Goldman does not only discover, but successfully disseminates, his team’s findings into clinical practice guidelines for children with pain in the acute care setting. He is leading the world’s largest online resource for acute care medication research — Pediatric Research in Emergency Therapeutics (PRETx.ORG).

Conflict of Interest Disclosure

Dr. Allan Grill, MD, CCFP(COE), MPH, FCFP, CCPE

Dr. Allan GrillDr. Allan Grill is an Associate Professor in the Department of Family and Community Medicine at the University of Toronto, and Chief of Family Medicine at Markham Stouffville Hospital. He enjoys an active, community-based clinical practice as the Lead Physician at the Markham Family Health Team and works part-time in the division of long-term care at Sunnybrook Health Sciences Centre. In 2016, Dr. Grill joined the College of Family Physicians of Canada as a physician advisor supporting the Department of Programs and Practice Support. As a former chair of the Committee to Evaluate Drugs — an expert advisory committee to the Ontario Ministry of Health and Long-Term Care on drug policy issues — as well as a previous member of the CADTH pan-Canadian Oncology Drug Review Expert Review Committee (pERC), he has experience in the critical appraisal of drug therapies and, additionally, in evaluating funding decisions for public formularies. In 2016, Dr. Grill received the Canadian Certified Physician Executive credential from the Canadian Medical Association and the Canadian Society of Physician Leaders, recognizing competency and excellence in physician leadership.

Conflict of Interest Disclosure

Mr. Allen Lefebvre

Mr. Allen LefebvreAllen Lefebvre has served in a number of management and volunteer leadership capacities in the last 25 years, primarily in the charitable and not-for-profit sectors. Now semi-retired, he was most recently engaged as the Project Coordinator for the Mâmawêyatitân Centre (formerly the North Central Shared Facility) in Regina — a major inner-city revitalization project.

Allen’s direct experience in the health care system came primarily as a result of his young son's cancer diagnosis in 1990 and the subsequent 15 years of treatment in the cancer care and critical care environments. Local and national volunteer involvement with the Canadian Cancer Society and the Candlelighters Canada Childhood Cancer Foundation led to his appointment as one of the founding members of the National Blood Safety Council in 1997. The organization advised the federal Minister of Health and conducted public forums on issues of blood safety in the wake of the Krever Commission. Allen served as a consumer representative and Vice-Chair of the Blood Safety Council until its dissolution in 2004. Allen has also been a public representative on the Drug Advisory Committee of Saskatchewan since 2010.

Conflict of Interest Disclosure

Heather Neville, BSc Pharm, MSc

Heather NevilleHeather Neville is a drug utilization pharmacist and pharmacy research coordinator with the Nova Scotia Health Authority in Halifax, Nova Scotia. She graduated from Dalhousie University with a BSc in Pharmacy in 1990 and a Master of Science degree with a focus in Community Health and Epidemiology in 2006.

Heather has extensive experience in drug use evaluation, formulary reviews, and hospital drug policy, and contributed to the Canadian Society of Hospital Pharmacist’s Drug Use Evaluation Services: Guidelines. As research coordinator, Heather facilitates research conducted by pharmacy staff, residents and students by providing training, mentoring, and grant-writing support. She maintains an active research program in the areas of pharmacy practice, medication adherence, drug utilization measurement, and pharmacoepidemiology. Heather is a Fellow of the Canadian Society of Hospital Pharmacists.

Conflict of Interest Disclosure

Dr. Danyaal Raza, MD, MPH, CCFP

Dr. Danyaal RazaDr. Raza is a staff physician with the Department of Family and Community Medicine at St. Michael’s Hospital, founding lead physician of the Sumac Creek Health Centre, and an assistant professor at the University of Toronto. He is a graduate of Harvard University’s Masters of Public Health program, where he was awarded a Frank Knox Fellowship, and is also a former fellow in Global Health at the University of Toronto’s Department of Family and Community Medicine. Dr. Raza completed post-graduate medical training at Queen’s University, and holds a Medical Doctorate and Bachelor of Engineering Science from Western University.

Dr. Raza’s academic work focuses on Canadian health care policy and, most recently, on federal and provincial policy governing the availability and costs of prescription drugs.

Conflict of Interest Disclosure

Dr. Emily Reynen, BSc. Pharm, PharmD, MD, CM

Dr. Emily ReynenDr. Reynen completed both undergraduate and doctorate degrees in Pharmacy at the University of Toronto Leslie Dan Faculty of Pharmacy. She obtained her medical degree from the McGill University Faculty of Medicine. Emily completed her core internal medicine residency training at Queen’s University, where she is currently completing Critical Care medicine subspecialty training.

Emily practised as a primary care pharmacist at the Two Rivers Family Health Team in Cambridge, Ontario. She later worked as a clinical research officer for CADTH and as a research coordinator at the Li Ka Shing Knowledge Institute at St. Michael’s Hospital.

Emily has experience in systematic review, rapid review, and network meta-analysis methodology. Her research interests include the comparison of research methodology, and quality improvement in the delivery of patient care.

Conflict of Interest Disclosure

Dr. Yvonne Shevchuk, BSP, PharmD

Dr. Yvonne ShevchukDr. Shevchuk is a Professor and Associate Dean Academic in the College of Pharmacy and Nutrition at the University of Saskatchewan, where her areas of teaching focus on infectious diseases, pharmacotherapeutics, and research methods/evidence-based pharmacotherapy and drug information. She is a long-time member of the Infectious Diseases Service at the Royal University Hospital and is involved in direct patient care. Yvonne has extensive committee experience, having served on both the Saskatchewan Formulary Committee and the Drug Quality Assessment Committee since 1991, and on the newly formed Drug Advisory Committee of Saskatchewan since January 2010. In addition, she is on the Board of the Saskatchewan Health Quality Council and the Advisory Board of RxFiles, and is Director of the Saskatchewan Drug Information Service.

Conflict of Interest Disclosure

Dr. Adil Virani, BSc Pharm, PharmD, FCSHP

Dr. Adil ViraniDr. Virani is a Director with Lower Mainland Pharmacy Services, which provides clinical and distribution services to hospitals within the Fraser Health Authority, Vancouver Coastal Health, and Providence Health Care, and some in the Provincial Health Services Authority. He is responsible for the Professional Practice portfolio, Residency and Student Education, Academic Detailing, and Pharmacy operations at some sites. He is an Associate Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia. He is also an editor of the Clinical Handbook of Psychotropic Drugs, now in its 21st edition, and editor of the Clinical Handbook of Psychotropic Drugs for Children and Adolescents, which is now in its 3rd edition. Adil is a member of the Education Working Group of the Therapeutics Initiative in British Columbia and the Human Drug Advisory Panel of the Patented Medicine Prices Review Board, and is a Fellow of the Canadian Society of Hospital Pharmacists.

Conflict of Interest Disclosure

Sally Bean, JD, MA

Dr. Adil ViraniSally Bean is the Director of the Health Ethics Alliance & Policy at Sunnybrook Health Sciences Centre in Toronto, Ontario. Sally earned a BA in Philosophy and English, an MA in Bioethics and Public Policy, and a Juris Doctorate. After law school, Sally completed a two-year fellowship in Clinical & Organizational Ethics through the University of Toronto Joint Centre for Bioethics. Additionally, she is a member of the University of Toronto Joint Centre for Bioethics, an adjunct lecturer in the Dalla Lana School of Public Health and the Institute of Health Policy, Management and Evaluation, and an associate member of the School of Graduate Studies at the University of Toronto.

Conflict of Interest Disclosure

Dr. Kerry Mansell, BSP, PharmD, MBA, ICD.D

Dr. Adil ViraniDr. Mansell is a Professor and Assistant Dean at the College of Pharmacy and Nutrition, University of Saskatchewan. His practice and research interests are in the area of diabetes. He teaches various endocrine subjects along with a variety of other pharmacotherapeutic areas to pharmacy students. He is an Associate Editor for the Canadian Journal of Diabetes and is a board member of the Canadian Foundation for Pharmacy.

Conflict of Interest Disclosure